Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

The National Parkinson Foundation’s Medical Director Publishes New Book on Breakthrough Therapies for Parkinson’s Disease

Sequel to 2013 Bestseller, “Parkinson’s Treatment: 10 Secrets to a Happier Life”

The National Parkinson Foundation’s (NPF) medical director, Michael S. Okun, M.D., has released a new book, “10 Breakthrough Therapies for Parkinson’s Disease.”  The book provides patients and families with all of the latest information on the potential breakthrough therapies for Parkinson’s disease.

“There is a worldwide crisis of misinformation; in many areas no information is available for people to understand the breakthrough therapies that will be necessary to living a better life with Parkinson’s disease,” said Okun, co-director of the UF Health Center for Movement Disorders and Neurorestoration in Gainesville, Florida, an NPF Center of Excellence. “We have to get the message out, and we have to make it understandable and available to everyone, regardless of where they live or what language they may speak."

This book is the sequel to his Amazon bestseller, “Parkinson’s Treatment: 10 Secrets to a Happier Life,” which was translated into over 20 languages. Okun is well-known for infusing his readers with optimism. In this book, he reviews all of the recent breakthrough ideas and therapies in Parkinson’s disease. He reviews the portfolio of breakthroughs spanning all fronts, including developments in drugs, vaccines, devices, genetics and behavior.  This book will inform, educate and inspire Parkinson’s disease patients and family members, as well as health care professionals and scientists.  

“Dr. Okun’s book conveys that a diagnosis of Parkinson’s is not the end of the road,” said Paul Blom, NPF’s interim CEO. “People with Parkinson’s and their families need to know that there are many innovative treatments on the horizon that will help make their lives better. Dr. Okun continues to give the Parkinson’s community the tools they need to be empowered and informed.”

Okun is internationally celebrated as both a neurologist and a leading researcher. He has often been referred to as “the voice of the Parkinson’s disease patient.” He was honored at the White House in 2015 as a Champion of Change for Parkinson’s disease. He has an international following on NPF’s “Ask the Doctor” online forum, and he is a professor of neurology at the University of Florida. His many books and “What’s Hot in PD?” blog posts on Parkinson.org are filled with up-to-date and practical information. Follow him on Twitter @MichaelOkun.

To learn more about the book or to purchase it, visit the Amazon Kindle store.

About Parkinson’s Disease (PD)
Affecting an estimated one million Americans and four to six million worldwide, Parkinson’s disease is the second most common neurodegenerative disease after Alzheimer’s and is the 14th leading cause of death in the United States. There is no cure for PD and 60,000 new cases are diagnosed each year in the United States alone.

About the UF Health Center for Movement Disorders and Neurorestoration (UFCMDNR)
The University of Florida Health Center for Movement Disorders and Neurorestoration is founded on the philosophy that integrated, interdisciplinary care is the most effective approach for patients with movement disorders and disorders involving a group of circuits in the brain called the basal ganglia. The Center delivers motor, cognitive and behavioral diagnoses, as well as various treatments all in one centralized location. Care is coordinated and provided by leading specialists from many advanced medical and surgical services. For more information, visit movementdisorders.ufhealth.org.

Monday, August 31, 2015
Parkinson's Foundation Study Finds Gender Disparities in Caregiving, with Women at a Disadvantage
Monday, December 4, 2017

Largest Clinical Study Tracking Parkinson’s Patients Over Time Shows Women with Parkinson’s Have Fewer Caregiving Resources than Men with Parkinson’s

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement
Wednesday, November 29, 2017

Six Awards Foster Patient-Driven Parkinson’s Research

Jesse Jackson Diagnosed with Parkinson's Disease
Friday, November 17, 2017

Rev. Jesse Jackson’s announcement today that he has been living with Parkinson’s Disease since 2015 further proves that receiving a diagnosis of Parkinson's is not a death sentence. There are many ways that people living with Parkinson's can control the symptoms of the disease with exercise and physical therapy to help maintain mobility and balance.

Update on Tozadenant Trial for Parkinson’s
Thursday, November 16, 2017

On 11/20/17, Acorda Therapeutics, Inc. announced that it is discontinuing the tozadenant clinical trial.  They concluded that they could not be confident that weekly white blood cell count screening would sufficiently ensure patient safety.

Parkinson’s Foundation Adds Marcia Mondavi Borger to Board of Directors
Tuesday, November 14, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Marcia Mondavi Borger to its Board of Directors.

Parkinson’s Foundation and Melvin Yahr International Parkinson’s Disease Foundation Announce Merger
Thursday, October 26, 2017

Parkinson’s Foundation Establishes ‘Dr. Melvin Yahr Research Award’ to Fund Neurology Fellows, Promote Leadership Diversity in Parkinson’s Research

Parkinson’s Foundation Welcomes Two New Board Members
Tuesday, October 24, 2017

Peter Goldman and Joshua Raskin Join Board of Directors

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

Parkinson's Foundation Unveils New Brand and Website
Thursday, October 19, 2017

NEW YORK and MIAMI /PRNewswire-USNewswire/ — The Parkinson's Foundation today announced the launch of its new brand and website following the recent merger of two legacy organizations – National Parkinson Foundation and Parkinson's Disease Foundation – as part of its mission to

FDA Approves Extended-Release Amantadine (GOCOVRI™) for Treatment of Dyskinesia
Friday, August 25, 2017

Statement from the Parkinson's Foundation Medical Director, Michael Okun, MD

Parkinson’s Foundation Announces $1.2 Million Investment to Advance Careers, Support Innovation of Early Career Parkinson’s Scientists
Tuesday, August 8, 2017

NEW YORK & MIAMI The Parkinson's Foundation is pleased to announce a $1.2 million investment in 27 career development and fellowship grants to support the work of promising early career scientists in the field of Parkinson's.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.